A, H., G, G., S, G., A, M., F, S., M, T., . . . P, S. (2026). Antiphosphatidylserine/prothrombin antibodies define a high-risk antiphospholipid syndrome profile associated with organ damage. Clinical chemistry and laboratory medicine, 64(5), 1133. https://doi.org/10.1515/cclm-2025-1565
Chicago Style (17th ed.) CitationA, Hoxha, Gobbo G, Gavasso S, Montagna A, Sartorello F, Tonello M, Zerbinati P, Ramonda R, and Simioni P. "Antiphosphatidylserine/prothrombin Antibodies Define a High-risk Antiphospholipid Syndrome Profile Associated with Organ Damage." Clinical Chemistry and Laboratory Medicine 64, no. 5 (2026): 1133. https://doi.org/10.1515/cclm-2025-1565.
MLA (9th ed.) CitationA, Hoxha, et al. "Antiphosphatidylserine/prothrombin Antibodies Define a High-risk Antiphospholipid Syndrome Profile Associated with Organ Damage." Clinical Chemistry and Laboratory Medicine, vol. 64, no. 5, 2026, p. 1133, https://doi.org/10.1515/cclm-2025-1565.
